237 related articles for article (PubMed ID: 14668709)
21. Comparison of iodixanol and ioversol for the prevention of contrast-induced nephropathy in diabetic patients after coronary angiography or angioplasty.
Hernández F; Mora L; García-Tejada J; Velázquez M; Gómez-Blázquez I; Bastante T; Albarrán A; Andreu J; Tascón J
Rev Esp Cardiol; 2009 Dec; 62(12):1373-80. PubMed ID: 20038403
[TBL] [Abstract][Full Text] [Related]
22. Renal safety of iodixanol.
McCullough PA
Expert Rev Cardiovasc Ther; 2006 Sep; 4(5):655-61. PubMed ID: 17081087
[TBL] [Abstract][Full Text] [Related]
23. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol.
Barrett BJ; Katzberg RW; Thomsen HS; Chen N; Sahani D; Soulez G; Heiken JP; Lepanto L; Ni ZH; Ni ZH; Nelson R
Invest Radiol; 2006 Nov; 41(11):815-21. PubMed ID: 17035872
[TBL] [Abstract][Full Text] [Related]
24. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.
Cheruvu B; Henning K; Mulligan J; Klippenstein D; Lawrence D; Gurtoo L; Gottlieb RH
J Comput Assist Tomogr; 2007; 31(4):493-8. PubMed ID: 17882021
[TBL] [Abstract][Full Text] [Related]
25. The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure.
Kuhn MJ; Chen N; Sahani DV; Reimer D; van Beek EJ; Heiken JP; So GJ
AJR Am J Roentgenol; 2008 Jul; 191(1):151-7. PubMed ID: 18562739
[TBL] [Abstract][Full Text] [Related]
26. Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures.
Laskey W; Aspelin P; Davidson C; Rudnick M; Aubry P; Kumar S; Gietzen F; Wiemer M;
Am Heart J; 2009 Nov; 158(5):822-828.e3. PubMed ID: 19853704
[TBL] [Abstract][Full Text] [Related]
27. Choice of contrast medium in patients with impaired renal function undergoing percutaneous coronary intervention.
Wessely R; Koppara T; Bradaric C; Vorpahl M; Braun S; Schulz S; Mehilli J; Schömig A; Kastrati A;
Circ Cardiovasc Interv; 2009 Oct; 2(5):430-7. PubMed ID: 20031753
[TBL] [Abstract][Full Text] [Related]
28. Effect of nonionic radiocontrast agents on the occurrence of contrast-induced nephropathy in patients with mild-moderate chronic renal insufficiency: pooled analysis of the randomized trials.
Sharma SK; Kini A
Catheter Cardiovasc Interv; 2005 Jul; 65(3):386-93. PubMed ID: 15926184
[TBL] [Abstract][Full Text] [Related]
29. Comparative Effect of Contrast Media Type on the Incidence of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis.
Eng J; Wilson RF; Subramaniam RM; Zhang A; Suarez-Cuervo C; Turban S; Choi MJ; Sherrod C; Hutfless S; Iyoha EE; Bass EB
Ann Intern Med; 2016 Mar; 164(6):417-24. PubMed ID: 26830055
[TBL] [Abstract][Full Text] [Related]
30. Renal safety in pediatric imaging: randomized, double-blind phase IV clinical trial of iobitridol 300 versus iodixanol 270 in multidetector CT.
Zo'o M; Hoermann M; Balassy C; Brunelle F; Azoulay R; Pariente D; Panuel M; Le Dosseur P
Pediatr Radiol; 2011 Nov; 41(11):1393-400. PubMed ID: 21713440
[TBL] [Abstract][Full Text] [Related]
31. Nephropathy after administration of iso-osmolar and low-osmolar contrast media: evidence from a network meta-analysis.
Biondi-Zoccai G; Lotrionte M; Thomsen HS; Romagnoli E; D'Ascenzo F; Giordano A; Frati G
Int J Cardiol; 2014 Mar; 172(2):375-80. PubMed ID: 24502883
[TBL] [Abstract][Full Text] [Related]
32. Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty [VIP] Trial Investigators.
Bertrand ME; Esplugas E; Piessens J; Rasch W
Circulation; 2000 Jan; 101(2):131-6. PubMed ID: 10637198
[TBL] [Abstract][Full Text] [Related]
33. Contrast-induced nephropathy in patients undergoing computed tomography (CONNECT) - a clinical problem in daily practice? A multicenter observational study.
Lencioni R; Fattori R; Morana G; Stacul F
Acta Radiol; 2010 Sep; 51(7):741-50. PubMed ID: 20707658
[TBL] [Abstract][Full Text] [Related]
34. Contrast-induced nephropathy-choice of contrast agents to reduce renal risk.
Katholi RE
Am Heart Hosp J; 2009; 7(1):45-9. PubMed ID: 19742433
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the nephrotoxicity of iodixanol in patients with predisposing factors to contrast medium induced nephropathy referred for contrast enhanced computed tomography.
Sandstede JJ; Roth A; Machann W; Kaupert C; Hahn D
Eur J Radiol; 2007 Jul; 63(1):120-3. PubMed ID: 17317065
[TBL] [Abstract][Full Text] [Related]
36. Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine.
Briguori C; Colombo A; Airoldi F; Morici N; Sangiorgi GM; Violante A; Focaccio A; Montorfano M; Carlino M; Condorelli G; Ricciardelli B
Kidney Int; 2005 Nov; 68(5):2250-5. PubMed ID: 16221226
[TBL] [Abstract][Full Text] [Related]
37. [Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents].
Hoshino A; Enomoto S; Kawahito H; Kurata H; Nakahara Y; Nakamura T
J Cardiol; 2007 Aug; 50(2):119-26. PubMed ID: 17802695
[TBL] [Abstract][Full Text] [Related]
38. Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media.
Liss P; Persson PB; Hansell P; Lagerqvist B
Kidney Int; 2006 Nov; 70(10):1811-7. PubMed ID: 17003814
[TBL] [Abstract][Full Text] [Related]
39. A meta-analysis of the risk of total cardiovascular events of isosmolar iodixanol compared with low-osmolar contrast media.
Zhang BC; Wu Q; Wang C; Li DY; Wang ZR
J Cardiol; 2014 Apr; 63(4):260-8. PubMed ID: 24397991
[TBL] [Abstract][Full Text] [Related]
40. Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography.
Hardiek KJ; Katholi RE; Robbs RS; Katholi CE
J Diabetes Complications; 2008; 22(3):171-7. PubMed ID: 18413220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]